Skip Navigation

Emerging Companies & Venture Capital

Emerging Companies & Venture Capital
Emerging Companies & Venture Capital
Expertise / Sectors / Emerging Companies & Venture Capital

Blakes has a long history of supporting emerging and growth-stage companies across Canada. There is currently an amazing gravity for emerging companies in Canada and we take great pride in working with Canadian and international innovation leaders. We are Canada’s oldest law firm, a 160 year old startup, and we’re overwhelmingly dedicated to supporting the success of Canadian businesses and strengthening their place in the global economy.

Emerging Companies and Venture Capital

As a full service business law firm, the Blakes national Venture Capital Group spans several specialty areas and provides strategic advice and legal counsel at each stage of a company’s lifecycle. This includes working with our clients on early, idea-stage issues, intellectual property, incorporation, governance policies, management agreements, commercial agreements, employment advice and regulatory approvals, through to financing their growth and exit strategies.

Emerging Companies and Venture Capital

Our team draws on national experience working with fund sponsors on structuring and managing venture capital investment funds and other investment vehicles as well, including fund formation, management, shareholder and investment agreements, governance, regulatory compliance and tax issues.

We also work closely with investor clients, as both buyers and sellers, to provide advice when formulating an investment strategy and when sourcing, structuring and executing an investment-related transaction.

Read more
Recent Experience

Representative examples of our recent venture capital experience in M&A, fund formation, early-stage financings and equity growth financings, including acting for:

  • BDC Capital on its co-investment in Precisely Microtechnology Corporation along with ACE Equity Partners, and ACE Equity Partners on related Canadian regulatory matters.

  • Perceptive Xontogeny Venture Fund, LP in connection with its series A venture capital investment in Zucara Therapeutics Inc.

  • D-Wave Systems Inc. on its C$27-million offering of Class I Convertible Preferred Shares.

  • Norwest Venture Partners and Georgian Partners on their acquisition of a controlling stake of Medgate Inc.

  • Desire2Learn Incorporated on its C$85-million series B funding and debt financing, with participation from Columbus Nova Technology Partners, Graham Holdings, Four Rivers Group, Aurion Capital, existing investors New Enterprise Associates and OMERS Ventures, and Silicon Valley Bank.

  • Georgian Partners as lead investor in the C$38-million Series B round in Influitive.

  • InvestEco Sustainable Food Fund II, L.P. on its investment in in Mama Earth Organics Inc. and its subsequent acquisition of Organic Food Delivery Corp.

  • Zymeworks Inc. in connection with its private placement of Class A Preferred Shares for aggregate gross proceeds of US$61.5-million.

  • CTI Life Sciences Fund on its C$22-million Series A investment in SutroVax.

  • D-Wave Systems Inc. on its C$30-million equity raise with funding from Goldman Sachs, BDC Capital, the Harris & Harris Group and DFJ.

  • Georgian Partners, Cisco Systems and Northleaf Venture Catalyst Fund on series B and C investments in eSentire, a cybersecurity software provider.

  • Scott Bommer (SAB Capital) on a recent investment as part of an investor group providing C$60-million in new funding to Hootsuite Media Inc.

  • Goodwater Capital on its series C investment in Frank & Oak.

  • Axine Water Technologies Inc. on its series A financing round that saw The Roda Group join existing investors Chrysalix Energy Venture Capital and BDC Venture Capital.

  • REGEN Energy on its US$7-million series B investment round led by a significant international energy company with participation from existing investors NGEN Partners and the BDC Venture Capital Energy/Cleantech Fund.

  • Endurance Wind Power on its series C round of financing led by Yaletown Venture Partners.

  • Iris Capital Fund III FCPR on its investment in Beyond the Rack Enterprises Inc.

  • Boreal Genomics Inc. on its series C round with new and existing venture capital investors.

  • GenomeDx Biosciences on its series B round in two tranches led by Merck Global Health Innovation Fund.

  • Square Victoria Digital Properties on its series A investment in Checkout51, a digital coupons and analytics developer.

  • Highland Consumer Fund, LLC in connection with its investment in DavidsTea Inc.

  • Skye Asset Management on its multi-tranched minority investment in an early-stage Canadian biotech company.

  • Highland Capital Partners LLC on its investment in Beyond the Rack Enterprises Inc.

  • Rover Parking on its seed investment round.